XEN glaucoma treatment system in the management of refractory glaucomas: a short review on trial data and potential role in clinical practice

XEN glaucoma treatment system in the management of refractory glaucomas: a short review on trial data and potential role in clinical practice

A De Gregorio,1 E Pedrotti,2 G Stevan,1 A Bertoncello,1 S Morselli1 1Ophthalmic Unit, San Bassiano Hospital, Bassano del Grappa, Italy; 2Eye Clinic, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Verona, Italy Abstract: The recent development of new devices th...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: De Gregorio A, Pedrotti E, Stevan G, Bertoncello A, Morselli S
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Xen Gel stent
Glaucoma
MIGS
Ophthalmology
RE1-994
Acceso en línea:https://doaj.org/article/44c09868525a47e2b0c7fd302cffeea1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:44c09868525a47e2b0c7fd302cffeea1
record_format dspace
spelling oai:doaj.org-article:44c09868525a47e2b0c7fd302cffeea12021-12-02T01:13:06ZXEN glaucoma treatment system in the management of refractory glaucomas: a short review on trial data and potential role in clinical practice1177-5483https://doaj.org/article/44c09868525a47e2b0c7fd302cffeea12018-04-01T00:00:00Zhttps://www.dovepress.com/xen-glaucoma-treatment-system-in-the-management-of-refractory-glaucoma-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483A De Gregorio,1 E Pedrotti,2 G Stevan,1 A Bertoncello,1 S Morselli1 1Ophthalmic Unit, San Bassiano Hospital, Bassano del Grappa, Italy; 2Eye Clinic, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Verona, Italy Abstract: The recent development of new devices that are significantly less invasive, collectively termed minimally invasive glaucoma surgery, offers new perspective of intraocular pressure reduction with less risk, short operating times, and rapid recovery. The aim of this work is to provide a panoramic review of the currently published clinical data to assess the potential role of XEN gel stent (Allergan PLC, Irvine, CA, USA) in the management of glaucoma, which is the only filtering minimally invasive glaucoma surgery device that allows the subconjunctival filtration. The ab interno placement of the XEN gel stent offers an alternative for lowering intraocular pressure in refractory glaucoma as a final step, and in patients intolerant to medical therapy as an early surgical approach with minimum conjunctival tissue disruption, restricted flow to avoid hypotony, and long-term safety. Keywords: glaucoma, gel stent, minimally invasive, surgery, subconjunctival drainageDe Gregorio APedrotti EStevan GBertoncello AMorselli SDove Medical PressarticleXen Gel stentGlaucomaMIGSOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 12, Pp 773-782 (2018)
institution DOAJ
collection DOAJ
language EN
topic Xen Gel stent
Glaucoma
MIGS
Ophthalmology
RE1-994
spellingShingle Xen Gel stent
Glaucoma
MIGS
Ophthalmology
RE1-994
De Gregorio A
Pedrotti E
Stevan G
Bertoncello A
Morselli S
XEN glaucoma treatment system in the management of refractory glaucomas: a short review on trial data and potential role in clinical practice
description A De Gregorio,1 E Pedrotti,2 G Stevan,1 A Bertoncello,1 S Morselli1 1Ophthalmic Unit, San Bassiano Hospital, Bassano del Grappa, Italy; 2Eye Clinic, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Verona, Italy Abstract: The recent development of new devices that are significantly less invasive, collectively termed minimally invasive glaucoma surgery, offers new perspective of intraocular pressure reduction with less risk, short operating times, and rapid recovery. The aim of this work is to provide a panoramic review of the currently published clinical data to assess the potential role of XEN gel stent (Allergan PLC, Irvine, CA, USA) in the management of glaucoma, which is the only filtering minimally invasive glaucoma surgery device that allows the subconjunctival filtration. The ab interno placement of the XEN gel stent offers an alternative for lowering intraocular pressure in refractory glaucoma as a final step, and in patients intolerant to medical therapy as an early surgical approach with minimum conjunctival tissue disruption, restricted flow to avoid hypotony, and long-term safety. Keywords: glaucoma, gel stent, minimally invasive, surgery, subconjunctival drainage
format article
author De Gregorio A
Pedrotti E
Stevan G
Bertoncello A
Morselli S
author_facet De Gregorio A
Pedrotti E
Stevan G
Bertoncello A
Morselli S
author_sort De Gregorio A
title XEN glaucoma treatment system in the management of refractory glaucomas: a short review on trial data and potential role in clinical practice
title_short XEN glaucoma treatment system in the management of refractory glaucomas: a short review on trial data and potential role in clinical practice
title_full XEN glaucoma treatment system in the management of refractory glaucomas: a short review on trial data and potential role in clinical practice
title_fullStr XEN glaucoma treatment system in the management of refractory glaucomas: a short review on trial data and potential role in clinical practice
title_full_unstemmed XEN glaucoma treatment system in the management of refractory glaucomas: a short review on trial data and potential role in clinical practice
title_sort xen glaucoma treatment system in the management of refractory glaucomas: a short review on trial data and potential role in clinical practice
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/44c09868525a47e2b0c7fd302cffeea1
work_keys_str_mv AT degregorioa xenglaucomatreatmentsysteminthemanagementofrefractoryglaucomasashortreviewontrialdataandpotentialroleinclinicalpractice
AT pedrottie xenglaucomatreatmentsysteminthemanagementofrefractoryglaucomasashortreviewontrialdataandpotentialroleinclinicalpractice
AT stevang xenglaucomatreatmentsysteminthemanagementofrefractoryglaucomasashortreviewontrialdataandpotentialroleinclinicalpractice
AT bertoncelloa xenglaucomatreatmentsysteminthemanagementofrefractoryglaucomasashortreviewontrialdataandpotentialroleinclinicalpractice
AT morsellis xenglaucomatreatmentsysteminthemanagementofrefractoryglaucomasashortreviewontrialdataandpotentialroleinclinicalpractice
_version_ 1718403195118551040

Ejemplares similares